Furthermore, tumor-derived TGF-β impairs the ability of pDCs to react to innate immune signals and inhibits type I IFN secretion, contributing to tumor growth by suppressing the infiltration of natural killers and recruitment of regulatory T cells [65]. Here, TGFB1 is linked to neoplasm.